ArticleJournal of cardiothoracic surgery2026
Bioinformatics identification of candidate biomarkers associated with T cell proliferation in atherosclerosis via WGCNA and machine learning.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAtherosclerosis (AS) is a complex chronic disease caused by the development of atherosclerotic plaques. T cell proliferation exerts a vital influence on development of the AS. This research aimed to conduct a comprehensive analysis to computationally screen candidate T cell proliferation-related biomarkers in AS and to explore their potential molecular mechanisms.
methodsThe transcriptional datasets of AS patients were obtained from the Gene Expression Omnibus (GEO) repository. To identify differentially expressed-T cell proliferation-related genes (DE-TPRGs), we integrated differential gene expression analysis with weighted gene co-expression network analysis (WGCNA), taking the intersection of DEGs and WGCNA-derived T cell proliferation-related module genes (TRMGs). Biomarkers were selected and validated through machine learning algorithms and expression levels. Moreover, a nomogram for predicting AS risk was developed based on the biomarkers. Enrichment analysis was employed to examine relevant pathways, while immune cell infiltration analysis was conducted to investigate the connection between immune cells and biomarkers. Finally, the construction of molecular regulatory and compound prediction networks, as well as molecular docking and molecular dynamic simulations, further validated the key regulatory roles of biomarkers in AS.
resultsOverall, two candidate genes (CLU and GUCY1B3) were determined to be potentially associated with the progression of AS. The nomogram constructed from these biomarkers showed good performance in predicting AS risk. Reactome rRNA processing and reactome translation were notably enriched in the pathways related to two biomarkers. CLU and GUCY1B3 showed positive computational corrections with activated dendritic cells, suggesting a possible involvement of these immune processes in AS. Moreover, 50 miRNAs (like hsa-miR-4504) and 68 transcription factors (TFs) (like MYB and TAL1) were found to have relationships with biomarkers. Importantly, the results and molecular dynamics simulation analyses predicted potential binding interactions between these candidate genes and bisphenol A, with GUCY1B3 demonstrating relatively greater binding stability.
conclusionsThe bioinformatics findings suggested that CLU and GUCY1B3 may serve as candidate biomarkers warranting further experimental investigation in AS associated with T cell proliferation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.